¼¼°èÀÇ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ - µ¿¹° À¯Çüº°, Á¦Ç° À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2021-2031³â)
Veterinary Healthcare Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Animal Type, Product Type, End User, and Geography
»óǰÄÚµå : 1761182
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 288 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,166,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 11,710,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå ±Ô¸ð´Â 2024³â 934¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 1,565¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2031³â CAGR 7.7%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖµÈ ¿äÀο¡´Â Àμö °øÅë °¨¿°ÁõÀÇ ±ÞÁõ ¹× µ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ ´ëóÀÇ ±Þµî µîÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¹Ý·Áµ¿¹° »çÀ°ÀÇ Áõ°¡, °¡Ãà »çÀ°ÀÇ Çʿ伺 ¹× ±¹Á¦ÀûÀÎ Áúº´ ¿¹¹æ ÇÁ·Î±×·¥Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» ²ø¾î¿Ã¸± °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ±×·¯³ª µ¿¹°¿ë ÀǾàǰÀÇ °³¹ß ¹× ½ÂÀÎ °úÁ¤ÀÇ º¹À⼺°ú ºñ¿ëÀÇ ³ôÀº ¼öÁØÀº ½ÃÀåÀÇ ÀúÇØ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.

HealthforAnimalsÀÇ 'Ç×»ýÁ¦ Çʿ伺À» ÁÙÀ̱â À§ÇÑ ·Îµå¸Ê' ÇÁ·Î±×·¥¿¡ µû¸£¸é 2019³â ÀÌÈÄ µ¿¹°À§»ý ºÐ¾ßÀÇ ¿¬±¸°³¹ß Ȱµ¿¿¡ ¾à 63¾ï ´Þ·¯°¡ ÅõÀڵǰí ÀÖ½À´Ï´Ù. ½ÃÀå ±â¾÷Àº Çõ½ÅÀûÀÎ Á¦Ç°À» µµÀÔÇÏ°í ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» È®º¸Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¸é, ¿¬±¸ °³¹ß(R&D)Àº, ¼öÀÇ»ç¿Í Ãà»ê »ý»êÀÚÀÇ Àå·¡ÀÇ ¿ä±¸¸¦ ¼±Á¡ÇÑ Çõ½ÅÀûÀÎ µ¿¹°¿ë ÀǾàǰ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ZoetisÀÇ ´ëóÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. 2024³â 12¿ù, Á¶¿¡Æ¼½º´Â Veterinary Meeting & Expo(VMX) 2025¿¡¼­ Vetscan OptiCellÀÇ ¼¼°èÀû ¹ß¸Å¸¦ ¹ßÇ¥Çß½À´Ï´Ù. À̴ īƮ¸®Áö½ÄÀ¸·Î ÀΰøÁö´É(AI)À» žÀçÇÑ ÃÖÃÊÀÇ ¼öÀÇÇ÷¾×Çпë Áø´Ü µµ±¸·Î ¸î ºÐ ¸¸¿¡ Á¤È®ÇÑ ÀλçÀÌÆ®¸¦ °¡Á®¿À´Â ÀüÇ÷±¸»êÁ¤(CBC) ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌó·³ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå¿¡¼­ÀÇ ¿¬±¸°³¹ß ³ë·Â ¹× ÅõÀÚÀÇ Áõ°¡´Â ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí Ä¡·á ¿É¼ÇÀ» °­È­Çϸç Áúº´ °ü¸® ´É·ÂÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

Áúº´°ü¸®¼¾ÅÍ(CDC)°¡ 2024³â 2¿ù¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é Àΰ£ÀÇ °¨¿°ÁõÀÇ 60% ÀÌ»óÀº µ¿¹°¿¡¼­ °¨¿°µÉ °¡´É¼ºÀÌ ÀÖÀ¸¸ç, Àΰ£ÀÇ ½ÅÈï °¨¿°ÁõÀÇ 75%´Â µ¿¹°¿¡¼­ À¯·¡ÇÕ´Ï´Ù. ¸Å³â Àμö °øÅë °¨¿°º´Àº ¼¼°è 25¾ï ¸íÀÇ »ç¶÷ °¨¿° ¹× 270¸¸ ¸íÀÇ »ç¸ÁÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¼¼°è µ¿¹°º¸°Ç±â±¸(WOAH)¿¡ µû¸£¸é »ç¶÷ÀÇ Áúº´À» ÀÏÀ¸Å°´Â º´¿øÃ¼ÀÇ ¾à 60%´Â °¡Ãà ¶Ç´Â ¾ß»ýµ¿¹°¿¡¼­ À¯·¡Çϰí, ¹ÙÀÌ¿ÀÅ×·¯ °ü·Ã º´¿øÃ¼ÀÇ 80%´Â µ¿¹°¿¡¼­ À¯·¡ÇÕ´Ï´Ù. ÀϹÝÀûÀÎ Àμö °øÅë °¨¿°º´À¸·Î´Â ¿¡º¼¶ó, ±¤°ßº´, »ì¸ð³Ú¶ó±Õ, źÀú±Õ, ¶óÀÓº´, ´ëÀå±Õ, Á¶·ùµ¶°¨ µîÀÌ ÀÖ½À´Ï´Ù. HIV´Â Àμö °øÅë °¨¿°ÁõÀ¸·Î ¹ß»óÇϰí, ±× ÈÄ »ç¶÷¿¡°Ô¸¸ º¯À̵Ǿú½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é °¡Ãà Àü¿°º´Àº ¼¼°è °¡Ãà »ý»ê·®ÀÇ 20% ÀÌ»óÀ» ÀÒ°í Ãà»ê¿¡ ÀÇÁ¸ÇÏ´Â ³óÃÌ Áö¿ªÀÇ »îÀ» À§ÇùÇϰí ÀÖ½À´Ï´Ù. Àμö °øÅë °¨¿°ÁõÀÇ Áõ°¡·Î ¿¹¹æÁ¢Á¾ ¹× Áø´Ü°Ë»ç µî ¿¹¹æ´ëÃ¥¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ ÁÖÀÎ ¹× ³ó°¡°¡ °¡ÃàÀ» º¸È£ÇÏ°í ³ª¾Æ°¡ Àΰ£ÀÇ °Ç°­À» ÁöŰ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Àμö °øÅë °¨¿°ÁõÀÇ °ü¸® ¹× Ä¡·á¿¡ ´ëÇÑ ´ëó´Â, »õ·Î¿î ¾àÀ̳ª Ä¡·á¹ýÀÇ °³¹ß¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á ¼±ÅÃÁöÀÇ È®´ë´Â ±â¾÷ÀÌ ÀÌ·¯ÇÑ °Ç°­ °úÁ¦¿¡ ´ëóÇϱâ À§ÇÑ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇÔÀ¸·Î½á ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

±â¾÷ ºÐ¼®¿¡¼­´Â Á¦Ç° Æ÷Æ®Æú¸®¿À(Á¦Ç° ¸¸Á·µµ, Á¦Ç° Ư¡, À̿밡´É¼º), ÃÖ±Ù ½ÃÀå µ¿Çâ(ÇÕº´ ¹× Àμö, ½ÅÁ¦Ç° Ãâ½Ã ¹× °­È­, ÅõÀÚ ¹× ÀÚ±Ý Á¶´Þ, ¼ö»ó, ÇÕÀÇ, Á¦ÈÞ ¹× Çù·Â, ÀÎÁö, È®´ë), °æÀï ±¸µµÀÇ º¸´Ù ÁÁÀº ÀÇ»ç°áÁ¤°ú ÀÌÇØ¸¦ µ½´Â Áö¿ª ÇöÁ¸À» ¹ÙÅÁÀ¸·Î µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀåÀ» Æò°¡ÇÏ°í ºÐ·ùÇÕ´Ï´Ù. º» º¸°í¼­¿¡¼­´Â, ¼¼°èÀÇ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå¿¡¼­ ÁÖ¿ä º¥´õÀÇ ÃÖ±ÙÀÇ Áß¿äÇÑ µ¿Çâ ¹× Çõ½Å¿¡ ´ëÇØ ±íÀÌ Á¶»çÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷Àº Boehringer Ingelheim International GmbH, Zoetis Inc, Merck &Co Inc, Shenzhen Mindray Animal Medical Technology Co.LTD, Neogen Corp, Idexx Laboratories Inc, Elanco Animal Health Inc, HIPRA SA, Ceva Sante Animale, Antech Diagnostics, Inc.ÀÔ´Ï´Ù.

µ¿¹° À¯Çü¿¡ µû¶ó µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀåÀº ÄÄÆÐ´Ï¾ð, °¡Ãà, °¡±ÝÀ¸·Î ³ª´¹´Ï´Ù. 2024³â µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå¿¡¼­´Â °¡Ãà ¹× °¡±Ý ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î ¼¼°èÀÇ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀåÀº ÀǾàǰ, ÀÇ·á±â±â, »ç·á ÷°¡¹°·Î ±¸ºÐµË´Ï´Ù. ÀǾàǰ ºÎ¹®ÀÌ 2024³â µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î, ¼¼°èÀÇ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀåÀº µ¿¹° º´¿ø, Áø·á¼Ò, ±âŸ·Î ºÐ·ùµË´Ï´Ù. µ¿¹° º´¿ø ºÎ¹®Àº 2024³â¿¡ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. µ¿¹° º´¿øÀº ¿¹¹æ Á¢Á¾ ¼­ºñ½º ¹× ¿¹¹æ Á¢Á¾ ÀÏÁ¤¿¡ °üÇÑ Àü¹®ÀûÀÎ Á¶¾ðÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. µ¿¹° º´¿øÀº ¹ÙÀÌ·¯½º º¤Åͳª °áÇÕ ¹é½Å µîÀÇ Çõ½ÅÀûÀÎ ¹é½ÅÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â°üÀº Á¾Á¾ »õ·Î¿î ±â¼ú°ú Á¦Ç°À» äÅÃÇÏ¿© »õ·Î¿î ¹é½Å Á¦Á¦ÀÇ »ç¿ëÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° ÁÖÀÎ ¹× Ãà»ê ³ó°¡°¡ µ¿¹° º´¿ø¿¡ Á¢±ÙÇÏ´Â ½Å·Ú°¡ ¹é½ÅÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ´Â °ÍÀÔ´Ï´Ù. ¹Ì±¹ ȨŸ¿îº´¿øÀÇ Àü±¹ ³×Æ®¿öÅ©ÀÎ VCA µ¿¹° º´¿øÀº ±¤°ßº´, µð½ºÅÛÆÛ, ¾Æµ¥³ë¹ÙÀÌ·¯½º(°³Àü¿°¼º °£¿°), ÆÄ¸£º¸¹ÙÀÌ·¯½º, ·¾Å佺ÇǶóÁõ, ÆÄ¶óÀÎÇ÷翣ÀÚ, Äڷγª¹ÙÀÌ·¯½º, ±â°üÁö¿° º¸¸£µ¥Å×¶ó, ¶óÀÓº´, °³ ÀÎÇ÷翣ÀÚ µîÀÇ ¹é½ÅÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¼öÀÇ»ç´Â ¹é½Å ¼±Åðú Åõ¿©¿¡ °üÇÑ Áöµµ¸¦ ÇÏ¿© µ¿¹°µéÀÌ ÀûÀýÇÑ ¿¹¹æÁ¢Á¾À» ¹ÞÀ» ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ´õºÒ¾î µ¿¹°º´¿øÀº ¾ö°ÝÇÑ ±ÔÁ¦±âÁØÀ» ÁؼöÇÏ¿© ¹é½ÅÀÌ ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î Åõ¿©µÉ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÄÄÇöóÀ̾𽺴 µ¿¹° ÀÇ·á¿¡ ´ëÇÑ »çȸÀû ½Å·Ú À¯Áö¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ±â¾÷Àº ´Ù¾çÇÑ À¯±âÀû ¹× ¹«±âÀû Àü·«À» ä¿ëÇϰí ÀÖ½À´Ï´Ù. À¯±âÀû Àü·«¿¡´Â ÁÖ·Î Á¦Ç° Ãâ½Ã¿Í Á¦Ç° ½ÂÀÎÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå¿¡¼­ º¼ ¼ö ÀÖ´Â ¹«±âÀû ¼ºÀå Àü·«¿¡´Â Àμö, Á¦ÈÞ, ÆÄÆ®³Ê½Ê µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå Àü·«¿¡ ÀÇÇØ, ½ÃÀå Âü°¡ ±â¾÷Àº »ç¾÷À» È®´ëÇØ, Áö¸®Àû Á¸Àç°¨À» ³ôÀÌ´Â °Í°ú µ¿½Ã¿¡, ½ÃÀå ÀüüÀÇ ¼ºÀå¿¡ °øÇåÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Àμö³ª Á¦ÈÞ µîÀÇ Àü·«Àº °í°´ ±â¹ÝÀ» °­È­Çϰí Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ ÁÖ¿ä ¹ßÀüÀÇ ¸î °¡Áö¸¦ ÀÌÇÏ¿¡ Á¦½ÃÇÕ´Ï´Ù.

2025³â, Mindray Animal Medical»ç´Â À¯·´¿¡ ÃÖÃÊÀÇ ÁöÁ¡À» ¼³¸³. ¹Îµå·¹ÀÌ¿Í ±× ÀÚȸ»çÀÎ ¹Îµå·¹ÀÌ µ¿¹° ¸ÞµðÄÃÀº À¯·´¿¡¼­ °ÔÀÌÆ®¿þÀÌ·Î ³×´ú¶õµå¸¦ ¼±ÅÃÇß½À´Ï´Ù. Mindray Animal MedicalÀÇ °æ¿ì ³×´ú¶õµå´Â À¯·´ÀÇ ÇãºêÀÌ¸ç ¹°·ù, ¿¬±¸°³¹ß, ¾ÖÇÁÅͼ¼ÀÏÁî, ±³À° ¼­ºñ½º Áö¿ø ¼¾ÅÍÀÔ´Ï´Ù.

2025³â ¼¼¹Ù´Â ÇÁ¶û½º¿¡ ¹ÙÀÌ¿À Á¦³ë¹é À¯ÀüüÇÐ ¿¬±¸¼Ò¸¦ °³¼³Çß½À´Ï´Ù. ÀÌ Ã·´Ü ½Ã¼³Àº ÷´Ü À¯Àüü ±â¼ú ¹× ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º¸¦ Ȱ¿ëÇÑ ¹Ì·¡ÀÇ ¹é½Å °³¹ß¿¡ ƯȭµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ¿¬±¸¼Ò´Â µ¿¹°ÀÇ »õ·Î¿î °¨¿°¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇÒ ¼ö ÀÖ´Â ¸ÂÃãÇü ¹é½Å ¼Ö·ç¼ÇÀ» »ý»êÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀåÀÇ Á¤¼¼

Á¦5Àå µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå ¼¼°èÀÇ µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå : ½ÃÀå ºÐ¼®

Á¦7Àå µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå ºÐ¼® : µ¿¹° À¯Çüº°

Á¦8Àå µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

Á¦9Àå µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå µ¿¹°¿ë ÇコÄÉ¾î ½ÃÀå : Áö¿ªº°

Á¦11Àå ¾÷°è Á¤¼¼

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦13Àå ºÎ·Ï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The veterinary Healthcare market size is projected to reach US$ 156.53 billion by 2031 from US$ 93.49 billion in 2024; it is estimated to register a CAGR of 7.7% during 2025-2031. Major factors driving the market growth include surging prevalence of zoonotic diseases and soaring initiatives for animal health. Further, the increasing pet ownership, livestock husbandry requirements, and international disease prevention programs is likely to boost the market during the forecast period. However high complexity and cost of veterinary drug development and approval processes are among the market deterrents.

According to the "Roadmap to Reducing the Need for Antibiotics" program by HealthforAnimals, approximately US $6.3 billion has been invested in research and development activities in the animal health sector since 2019. Market players are introducing innovative products and securing regulatory approvals for the same. For instance, research and development (R&D) is at the center of Zoetis' efforts to provide innovative animal health solutions that anticipate the future needs of veterinarians and livestock producers. In December 2024, Zoetis announced the global launch of Vetscan OptiCell at the Veterinary Meeting & Expo (VMX) 2025. It is the first cartridge-based, artificial intelligence (AI) powered diagnostic tool for veterinary hematology, providing complete blood count (CBC) analysis that delivers accurate insights in minutes. Thus, the increasing R&D efforts and investments in the animal healthcare market are fostering innovation, enhancing treatment options, and improving disease management capabilities.

According to an article published by the Center for Disease Control (CDC) in February 2024, over 60% of infectious diseases in humans can be transmitted from animals, and 75% of emerging infectious diseases in humans originate from animals. Each year, zoonotic diseases cause 2.5 billion human infections and 2.7 million deaths worldwide. According to the World Organization for Animal Health (WOAH), about 60% of pathogens causing human diseases come from domestic animals or wildlife, and 80% of bioterrorism-related pathogens originate from animals. Common zoonotic diseases include Ebola, rabies, salmonella, anthrax, Lyme disease, E. coli, and bird flu. HIV originated as a zoonosis before mutating into human-only strains. As per the World Health Organization (WHO), animal diseases lead to over 20% of global production losses in livestock, threatening the livelihoods of rural communities dependent on animal agriculture. The increasing incidences of zoonotic diseases are propelling the demand for preventive measures, including vaccinations and diagnostic tests. This increased demand is driving the emphasis on animal healthcare products and services, as pet owners and farmers aim to protect their animals and, in turn, safeguard human health. Efforts to manage and treat zoonotic diseases have fueled the development of new medications and treatments. This expansion in treatment options contributes to market growth as companies invest in research and development to address these health challenges.

The company analysis evaluates and categorizes the veterinary healthcare market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global veterinary healthcare market. The key market players are Boehringer Ingelheim International GmbH, Zoetis Inc, Merck & Co Inc, Shenzhen Mindray Animal Medical Technology Co., LTD, Neogen Corp, Idexx Laboratories Inc, Elanco Animal Health Inc, HIPRA SA, Ceva Sante Animale, and Antech Diagnostics, Inc.

Based on animal type, the veterinary healthcare market is divided into companion, livestock, and poultry. The livestock and poultry segment held the largest share of the veterinary healthcare market in 2024.

By product type, the global veterinary healthcare market is segmented into pharmaceuticals, medical devices, and feed additives. The pharmaceuticals segment held the largest share of the veterinary healthcare market in 2024.

By end user, the global veterinary healthcare market is categorized into veterinary hospitals, clinics, and others. The veterinary hospitals segment held the largest share of the veterinary healthcare market in 2024. Veterinary hospitals offer vaccination services and expert advice on immunization schedules. They provide innovative vaccines such as viral vectors and conjugated vaccines. These institutions often adopt new technologies and products and promote the use of novel vaccine formulations. The trust placed in veterinary hospitals by pet owners and livestock farmers enhances vaccine adoption. VCA Animal Hospitals, a national network of hometown hospitals in the US, offer vaccines, including rabies, distemper, adenovirus (infectious canine hepatitis), parvovirus, leptospirosis, parainfluenza, coronavirus, Bordetella bronchiseptica, Lyme disease, and canine influenza. Veterinarians provide guidance on vaccine selection and administration, ensuring that animals receive appropriate immunizations. Additionally, veterinary hospitals adhere to strict regulatory standards, ensuring that vaccines are administered safely and effectively. This compliance helps maintain public trust in veterinary care.

Various organic and inorganic strategies are adopted by companies operating in the veterinary healthcare market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the veterinary healthcare market are listed below.

In 2025, Mindray Animal Medical Established the First Branch in Europe. Mindray and its subsidiary, Mindray Animal Medical, selected the Netherlands as the gateway in Europe. For Mindray Animal Medical, the Netherlands is the hub for Europe and the support center for logistics, R&D, after-sales, and training services.

In 2025, Ceva inaugurated the Biogenovac genomics laboratory in France. This state-of-the-art facility is dedicated to developing future vaccines by leveraging advanced genomic technologies and bioinformatics. The laboratory aims to create tailored vaccine solutions that can rapidly respond to emerging infectious diseases in animals.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Veterinary Healthcare Market Landscape

5. Veterinary Healthcare Market - Key Market Dynamics

6. Veterinary Healthcare Market - Global Market Analysis

7. Veterinary Healthcare Market Analysis - by Animal Type

8. Veterinary Healthcare Market Analysis - by Product Type

9. Veterinary Healthcare Market Analysis - by End User

10. Veterinary Healthcare Market - Geographical Analysis

11. Industry Landscape

12. Company Profiles

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â